From Intention to Action:Scoring Your College Goals

Depression Clinical Trial

Official title:

Scoring Your College Goals: A Study to Increase Self-Efficacy in First-Year College Students

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05047081
• Other study ID #: 21-0500
• Status: Active, not recruiting
• Phase: N/A
• Start date: August 27, 2021
• Est. completion date: April 30, 2022

Study information

• Verified date: February 2022
• Source: The Zucker Hillside Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The current study aims to prevent the developmental of mental health symptoms in first-year college students through providing a workshop aimed at preparing students for the academic, social, and personal challenges associated with typical college experiences. Specifically, the study hypothesizes that first-year student students who participate in a workshop on college readiness will report fewer symptoms of depression and anxiety, higher levels of self-esteem, and better academic performance compared to a similar group of students who do not receive the intervention (the control group). Students in the intervention group will participate in a one-time, two-hour workshop that discusses expectations about college, setting goals that are aligned with one's values, predicting barriers to achieving these goals, and how to overcome these obstacles. The workshop will provide students with external resources (both on and off campus) for obtaining additional support to address barriers that arise during their college experiences. Students will complete questionnaires about symptoms of depression, anxiety, and their ability to cope with stress before the workshop, after the workshop, and at the end of their first semester. At the end of the Fall 2021 semester, students will be asked to share information about their Grade Point Average (GPA) and academic status. The investigators predict that at the end of the semester, those students who participated in the workshop will report lower levels of depression, anxiety and stress, higher levels of self-esteem, and a higher GPA compared to students who did not receive the intervention. Students who participated in the workshop will also be more likely to continue (enrolled in the Spring 2022 semester) compared to controls.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 126
• Est. completion date: April 30, 2022
• Est. primary completion date: March 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• First-year, first semester freshman enrolled in Psychology 100 courses at CUNY College of Staten Island.

Exclusion Criteria:

• Under 18 years old

• Violation of inclusion criteria

Related Conditions & MeSH terms

• Anxiety
• Depression

Intervention

Behavioral:
• Scoring Your College Goals Workshop
A two-hour virtual college readiness workshop.

Other:
• Placebo
Placebo Treatment-As-Usual Group which does not receive the workshop intervention

Locations

Country	Name	City	State
United States	CUNY College of State Island	Staten Island	New York

Sponsors (2)

Lead Sponsor	Collaborator
The Zucker Hillside Hospital	College of Staten Island, the City University of New York

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in Self-Reported Depression Symptoms on the DASS-21	Change in Depression Symptoms as measured by self-report on the Depression sub scale of the Depression, Anxiety and Stress Scale (DASS-21). Each sub scale of the DASS-21 has a range of 0-(lowest) to 42 (highest) with higher scores indicating worsening levels of psychopathology.	Three Months
Primary	Change in Anxiety Symptoms as measured by the DASS-21	Participants in the intervention arm but not the placebo group will demonstrate change in Depression Symptoms as measured by participant self-report on the Anxiety subscale of the Depression, Anxiety and Stress Scale (DASS-21).	Three Months
Secondary	Change in self-efficacy as measured by the Coping Self-Efficacy Scale	Participants in the intervention group but not the control group will demonstrate significant change in self-reported self-efficacy scores as measured by the Coping Self-Efficacy Scale (CSE). Each sub scale of the CSE has a range of scores from 0 (lowest) to 60 (highest) with a higher score representing better (improved) coping self-efficacy.	Three Months
Secondary	Change in Coping abilities as measured by the Brief COPE	Participants in the intervention group but not the control group will demonstrate significant change in their ability to cope with stress as measured by self-reported total scores on the Brief COPE. The fourteen sub scales of the Brief COPE each have a range of 0 (lowest) to 8 (highest) with higher scores indicating higher levels of coping ability.	Three Months